Skip to main content
STARSOURCE MULTITRADE LIMITED logo

STARSOURCE MULTITRADE LIMITED — Investor Relations & Filings

Ticker · 506365 ISIN · INE320M01019 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 319 across all filing types
Latest filing 2022-10-13 Regulatory Filings
Country IN India
Listing BSE.NS 506365

About STARSOURCE MULTITRADE LIMITED

https://starsourcemultitrade.com/

STARSOURCE MULTITRADE LIMITED is a commercial entity engaged in the wholesale distribution and trading of a broad range of products. The organization primarily focuses on the procurement, supply, and logistics of textiles, fabrics, and related materials. Its core operations involve managing complex supply chains to connect manufacturers with diverse market segments. The company prioritizes the sourcing of high-quality goods and maintains a robust distribution network to ensure efficient delivery and market responsiveness. By focusing on bulk trading and strategic sourcing, the firm serves as a key intermediary in the movement of materials across various commercial channels.

Recent filings

Filing Released Lang Actions
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting scheduled for October 20, 2022. The purpose of the meeting is to consider and approve the unaudited financial statements for the quarter and half year ended September 30, 2022, along with the limited review report. The document does not contain any financial data or the actual financial statements; it is merely an announcement of the meeting where such reports will be considered. The length is only 1274 characters, which is very short and consistent with an announcement rather than a full report. Therefore, this document fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain substantive financial data or the report itself.
2022-10-13 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2022. It is a compliance confirmation certificate issued by the company's Registrar and Share Transfer Agent, confirming dematerialization of shares and related compliance. The document contains no financial statements or substantive financial data, but rather a regulatory compliance certificate. It is not an annual or interim report, earnings release, or any other financial report. It is also not a report publication announcement since it contains the actual certificate text and details. The document fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate filing.
2022-10-03 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings Classification · 95% confidence The document is a short notification addressed to the Bombay Stock Exchange regarding the issue of a duplicate share certificate due to loss of the original certificate. It references Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, which pertains to share certificate matters. The content is an announcement about a specific shareholder's share certificate issue and does not contain financial data, management discussion, or report content. It is not a financial report, earnings release, or management report. It is also not a voting result, board change, or capital change announcement. The document is a regulatory announcement related to share certificates, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-09-29 English
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading ....
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to the stock exchange about the closure of the trading window for designated persons due to insider trading regulations. It references the upcoming financial results for the quarter ended September 30, 2022, but does not contain any financial data, analysis, or detailed report content. The document is an announcement related to compliance and trading restrictions rather than a financial report or detailed filing. It is also very short (1148 characters), indicating it is not a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2022-09-28 English
Voting Results and Scrutinizer's Report of the 80TH Annual General Meeting as per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements), 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a communication addressed to the Bombay Stock Exchange regarding the voting results and scrutinizer's report of the 80th Annual General Meeting (AGM) held on September 8, 2022. It includes detailed voting results on various resolutions such as adoption of audited financial statements, appointment and reappointment of directors, and regularization of an independent director. The document is not the full AGM presentation or materials but rather the official announcement of the voting outcomes and related reports as required by SEBI regulations. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length (8161 characters) and content confirm it is not a brief report publication announcement or a full annual report. Therefore, the correct classification is DVA with high confidence.
2022-09-10 English
Proceedings/Outcome of the 80th Annual General Meeting as per Regulation 30 Read With Schedule III of SEBI (Listing Obligations and Disclosure Requirements), 2015
AGM Information Classification · 100% confidence The document is a detailed account of the proceedings of the 80th Annual General Meeting (AGM) of Chemo Pharma Laboratories Limited held on September 8, 2022. It includes information about the meeting's agenda, attendance, voting procedures, and resolutions passed. The document references the AGM notice, Board Report, Auditor's Report, and financial statements but does not contain the full financial reports themselves. It also mentions the e-voting process and the appointment of a scrutinizer. The content is consistent with a formal summary or minutes of an AGM rather than the full Annual Report or financial statements. Therefore, the document fits the category of AGM Information (AGM-R). The document length (7132 characters) supports that it is a detailed meeting proceeding rather than a brief announcement or a full report.
2022-09-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.